Economic burden of hypoglycemia in patients with Type 2 diabetes

References

• DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329(14), 977–986 (1993).
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HAW et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ321(7258), 405–412 (2000).
   PubMed Web of Science ®Google Scholar
• ADVANCE. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med.358(24), 2560–2572 (2008).
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Craven T, Banerji MA et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in Type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet376(9739), 419–430 (2010).
   PubMed Web of Science ®Google Scholar
• Ray KK, Seshasai SRK, Wijesuriya S et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet373(9677), 1765–1772 (2009).
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in Type 2 diabetes. N. Engl. J. Med.359(15), 1577–1589 (2008).
   PubMed Web of Science ®Google Scholar
• Turnbull FM, Abraira C, Anderson RJ et al.; CONTROL Group. Intensive glucose control and macrovascular outcomes in Type 2 diabetes. [Erratum appears in Diabetologia. 2009 Nov;52(1):2470 Note: Control Group [added]]. Diabetologia52(11), 2288–2298 (2009).
   PubMed Web of Science ®Google Scholar
• ACCORD. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med.358(24), 2545–2559 (2008).
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with Type 2 diabetes. N. Engl. J. Med.360(2), 129–139 (2009).
   PubMed Web of Science ®Google Scholar
• Zoungas S, Patel A, Chalmers J et al. Severe hypoglycemia and risks of vascular events and death. N. Engl. J. Med.363(15), 1410–1418 (2010).
   PubMed Web of Science ®Google Scholar
• Wright AD, Cull CA, Macleod KM, Holman RR. Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J. Diabetes Complications20(6), 395–401 (2005).
   Google Scholar
• Miller ME, Bonds DE, Gerstein HC et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ340, b5444 (2010).
   PubMed Web of Science ®Google Scholar
• Noh RM, Graveling AJ, Frier BM. Medically minimising the impact of hypoglycaemia in Type 2 diabetes: a review. Expert Opin. Pharmacother.12(14), 2161–2175 (2011).
   PubMed Web of Science ®Google Scholar
• Banarer S, Cryer PE. Hypoglycemia in Type 2 diabetes. Med. Clin. North Am.88(4), 1107–1116 (2004).
   PubMed Web of Science ®Google Scholar
• Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab. Res. Rev.24(2), 87–92 (2008).
   PubMed Web of Science ®Google Scholar
• Graveling AJ, Frier BM. Hypoglycaemia: an overview. Prim. Care Diabetes3(3), 131–139 (2009).
   PubMedGoogle Scholar
• Halimi S. Acute consequences of hypoglycaemia in diabetic patients. Diabetes Metab.36(Suppl. 3), S75–S83 (2010).
   PubMed Web of Science ®Google Scholar
• Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns.68(1), 10–15 (2007).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care31(3), 596–615 (2008).
   PubMed Web of Science ®Google Scholar
• O’Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical costs of complications resulting from Type 2 diabetes in the U.S. Diabetes Care21(7), 1122–1128 (1998).
   PubMed Web of Science ®Google Scholar
• Bullano MF, Fisher MD, Grochulski WD, Menditto L, Willey VJ. Hypoglycemic events and glycosylated hemoglobin values in patients with Type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products. Am. J. Health Syst. Pharm.63(24), 2473–2482 (2006).
   PubMed Web of Science ®Google Scholar
• Heaton A, Martin S, Brelje T, Heaton A, Martin S, Brelje T. The economic effect of hypoglycemia in a health plan. Manag. Care Interface16(7), 23–27 (2003).
   PubMedGoogle Scholar
• Lundkvist J, Berne C, Bolinder B, Jönsson L. The economic and quality of life impact of hypoglycemia. Eur. J. Health Economics6(3), 197–202 (2005).
   PubMedGoogle Scholar
• Jönsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with Type 2 diabetes in Sweden. Value Health9(3), 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Allicar MP, Megas F, Houzard S, Baroux A, Le Thai F, Augendre-Ferrante B. Frequency and cost of hospitalization for hypoglycemia in France in 1995. Presse Medicale29(12), 657–661 (2000).
   PubMed Web of Science ®Google Scholar
• Rhoads GG, Orsini LS, Crown W et al. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J. Occup. Environ. Med.47(5), 447–452 (2005).
   PubMed Web of Science ®Google Scholar
• Holstein A, Plaschke A, Egberts EH. Incidence and costs of severe hypoglycemia. Diabetes Care25(11), 2109–2110 (2002).
   PubMed Web of Science ®Google Scholar
• Ginde AA, Espinola JA, Camargo CA. Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993–2005. Diabetes Care31(3), 511–513 (2008).
   PubMed Web of Science ®Google Scholar
• Leese GP, Wang J, Broomhall J et al. Frequency of severe hypoglycemia requiring emergency treatment in Type 1 and Type 2 diabetes. Diabetes Care26(4), 1176–1180 (2003).
   PubMed Web of Science ®Google Scholar
• Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet. Med.25(3), 245–254 (2008).
   PubMed Web of Science ®Google Scholar
• Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in Type 1 and Type 2 diabetes. Curr. Med. Res. Opin.21(9), 1477–1483 (2005).
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health14(5), 665–671 (2011).
   PubMed Web of Science ®Google Scholar
• Barnett A. Avoiding hypoglycaemia while achieving good glycaemic control in Type 2 diabetes through optimal use of oral agent therapy. Curr. Med. Res. Opin.26(6), 1333–1342 (2010).
   PubMed Web of Science ®Google Scholar
• Rodbard H, Jellinger P, Davidson J et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 diabetes mellitus: an algorithm for glycemic control. Endocr. Pract.15(6), 540–559 (2009).
   PubMed Web of Science ®Google Scholar